HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 615792Generated: October 27, 2026
Trifluoroacetic acid → (6R)-3-[(2-amino-[1,3]thiazolo[4,5-c]pyridin-5-ium-5-yl)methyl]-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
https://huagongshe.com/reaction/615792

Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | Anisole | HCID 7519 | — |
| Reactant | (1,3)Thiazolo(4,5-c)pyridin-2-amine | HCID 14252938 | — |
| Reactant | benzhydryl (6R)-3-(iodomethyl)-7-[[(2Z)-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]cyclobutyl]oxyimino-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | HCID 172953015 | — |
| Solvent | Formic Acid | HCID 284 | — |
| Solvent | Hydrochloric Acid | HCID 313 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Product | (6R)-3-[(2-amino-[1,3]thiazolo[4,5-c]pyridin-5-ium-5-yl)methyl]-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | HCID 177705152 | — |
Reaction Steps
A mixture of benzhydryl 7-[(Z)-2-(1-t-butoxycarbonylcyclobut-1-oxyimino)-2-(2-tritylaminothiazol-4-yl)-acetamido]-3-iodomethyl-3-cephem-4-carboxylate [VIIe'] (643 mg, 0.6 mmole) and 2-aminothiazolo[4,5-c]pyridine (100 mg, 0.67 mmole) in 3 ml of dry DMSO was stirred at room temperature for an hour. The reaction mixture was diluted with ether (50 ml) to separate a precipitate, which was triturated with ether (50 ml). The resulting precipitate was dissolved in 30 ml of methylene chloride. After filtration, the filtrate was evaporated and the residue was triturated with isopropyl ether to give 622 mg of the crude blocked quaternary salt as a brown powder. A mixture of the crude solid (450 mg, 0.37 mmole), anisole (0.5 ml), trifluoroacetic acid (5 ml), and water (0.3 ml) was stirred at room temperature for 1.25 hours and concentrated under reduced pressure. The residue was triturated with isopropyl ether (70 ml), and the precipitate was isolated by filtration to give 330 mg of crude final product as a yellow powder, which was dissolved in a mixture of 85% formic acid (1 ml) and concentrated hydrochloric acid (0.05 ml). The solution was allowed to stand at room temperature for 20 minutes and adsorbed on a column of HP-20 resin (40 ml). It was eluted with water (150 ml), 30% aqueous methanol (150 ml) and 50% aqueous methanol (300 ml). Fractions containig the desired product were combined, concentrated and lyophilized to give 167 mg of powder, which was found to be a mixture of the Δ2 and Δ3 isomers by NMR and HPLC. It was further purified by column chromatography using the packing of the PrepPAK-500/C18 (Waters) (20 ml) and the eluate with water (400 ml) was collected in 10 ml fractions, which were monitored by HPLC. The desired fractions were combined, concentrated and lyophilized to afford 58 mg (20%) of Ik as a pale yellow amorphous powder. Mp >150° C. (dec.). Estimated purity 80% (by HPLC).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04500526 |
|---|
| Source dataset | uspto-grants-1985_02 |
|---|
| ORD ID | ord-f2809593d6c04da8b22e1ba11a9daae1 |
|---|
| Source note | uspto-grants-1985_02 |
|---|